Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 EUR | -6.25% |
|
+5.26% | +65.14% |
05-16 | GeNeuro SA Announces Last Patient Last Visit in Its Post-Covid Trial and Confirms Top-Line Results by End of June 2024 | CI |
03-20 | Geneuro SA Announces Appointments of Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+65.14% | 60.82M | |
+38.36% | 52.73B | |
+38.85% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- GNRO Stock
- News GeNeuro SA
- GeNeuro Raises EUR5 Million from Share Issue